Skip to content

Exagen Inc. XGN Book value per share

Book value per share at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$65.77+7.3%
Vor Biopharma logo
Vor BiopharmaVOR
-$3.50-133%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$3.40-70.9%
CareDx logo
CareDxCDNA
$5.90-14.0%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$254.15+6.4%
Revvity logo
RevvityRVTY
$64.20+1.1%

Other financials

Income statement

See full
Revenue$17.3M+11.7%
Gross profit$10.2M+11.9%
Operating income-$3.4M-1.5%
Net income-$4.0M-5.7%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$21.7M+90.6%
Total debt$27.1M+15.8%
Total equity$14.4M+125%
Total assets$52.0M+28.9%

Cash flow

See full
Operating cash flow-$10.4M+2.4%
CapEx$228.0K+102%
Free cash flow-$10.6M+1.3%

Valuation

See full
Market cap$112.34M-26.5%
Enterprise value$117.78M-20.3%
P/S1.6×-1.0×

Profitability

See full
Gross margin58.3%-1.0pp
Operating margin-20.6%-2.9pp
Net margin-29.5%+2.5pp
FCF margin-27.5%

Returns & leverage

See full
Return on equity-193.6%+355pp
Debt / equity1.9×-1.8×
Current ratio3.5×+1.1×

Where this comes from

Calculated from Exagen Inc.’s reported figures.

Based on the most recent quarter.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exagen Inc.'s book value per share?
Exagen Inc. (XGN) reported book value per share of $0.61 in Q1 2026.
How has Exagen Inc.'s book value per share changed year-over-year?
Exagen Inc.'s book value per share increased by 75.4% year-over-year, from $0.35 to $0.61.
What is the long-term trend for Exagen Inc.'s book value per share?
Over 5 years (2020 to 2025), Exagen Inc.'s book value per share has grown at a -24.6% compound annual growth rate (CAGR), from $3.31 to $0.81.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.